Very Long-term Outcome of Minimally Invasive Direct Coronary Artery Bypass

Giorgio Mastroiacovo1, Sabrina Manganiello2, Sergio Pirola2

  • 1Department of Cardiovascular Surgery, Monzino Cardiology Center Scientific Institute for Research, Hospitalization, and Healthcare (IRCCS), Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Insights

Minimally invasive direct coronary artery bypass (MIDCAB) surgery offers excellent long-term survival and freedom from major adverse cardiocerebral-related events (MACCE). This approach also reduces hospital stay and blood transfusions compared to traditional sternotomy.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Long-Term Outcomes

Background:

  • Minimally invasive direct coronary artery bypass (MIDCAB) is a surgical technique for revascularizing the left descending coronary artery.
  • This procedure utilizes the left internal mammary artery and is considered low-impact.

Purpose of the Study:

  • To evaluate the safety and long-term efficacy of MIDCAB.
  • Assess overall survival rates up to 20 years post-procedure.
  • Determine freedom from major adverse cardiocerebral-related events (MACCE) after two decades.

Main Methods:

  • Retrospective analysis of 141 patients undergoing MIDCAB between 1997 and 2017.
  • Focus on 133 patients who had left descending coronary artery revascularization using the left mammary artery via full median sternotomy.
  • Kaplan-Meier curves and Cox multivariable analysis were employed for outcome assessment.

Main Results:

  • Actuarial survival rates reached 70% at 20 years.
  • Freedom from MACCE (myocardial infarction, stroke, cardiac death) was 61% at 20 years.
  • MIDCAB demonstrated significantly shorter hospital stays and fewer blood transfusions compared to full sternotomy.

Conclusions:

  • MIDCAB provides satisfactory very long-term clinical outcomes regarding survival and MACCE.
  • The procedure significantly reduces hospital length of stay and blood transfusions.
  • MIDCAB appears to improve prognosis for cardiac-related and all-cause events compared to full sternotomy.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
157
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
204
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
135